Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2025

Conditions

Androgenic Alopecia

Interventions

DRUG

FOL100

FOL100 lotion

DRUG

Propecia 1Mg Tablet

Oral Finasteride

Trial Locations (3)

RECRUITING

Rabin Medical Center, Petah Tikva

RECRUITING

Sheba Medical Center, Ramat Gan

RECRUITING

Sourasky Medical Center, Tel Aviv